RADX

Radiopharm Theranostics Limited
D

RADX

5.19000
USD
0.12
(2.37%)
مغلق
حجم التداول
762
الربح لكل سهم
-3
العائد الربحي
-
P/E
-1
حجم السوق
40,913,626
أصول ذات صلة المقالات

العنوان: Radiopharm Theranostics Limited

القطاع: Healthcare
الصناعة: Biotechnology
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.